<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02899689</url>
  </required_header>
  <id_info>
    <org_study_id>15-0272</org_study_id>
    <nct_id>NCT02899689</nct_id>
  </id_info>
  <brief_title>Induction of Labor in Women With Unfavorable Cervix: Dilapan Versus Foley Bulb</brief_title>
  <official_title>Induction of Labor in Women With Unfavorable Cervix: Randomized Control Study Comparing Dilapan to Foley Bulb</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Medical Branch, Galveston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medicem International CR s.r.o.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Medical Branch, Galveston</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Women undergoing mechanical cervical ripening for labor induction will be randomized to&#xD;
      Dilapan-S® versus Foley bulb. The investigators hypothesized that osmotic cervical dilators&#xD;
      (Dilapan-S®) are as effective as Foley bulb catheter in rates of vaginal delivery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Historically, mechanical methods were the first methods developed to ripen the cervix or to&#xD;
      induce labor. Dilapan-S® a synthetic osmotic cervical dilator made of a patented hydrogel&#xD;
      (AQUACRYL), works by stimulating the release of endogenous prostaglandins, which degrade&#xD;
      collagen fibers and soften the cervix. Additionally, it dilates the cervix gradually and the&#xD;
      effect is gentle as well as predictable. Recently, Dilapan-S® has been approved by the FDA as&#xD;
      a mechanical dilator for cervical ripening. There are no data comparing this newly approved&#xD;
      Dilapan-S® to the Foley catheter, the most commonly used mechanical dilator method.&#xD;
      Therefore, The investigators propose a randomized controlled trial to determine the efficacy&#xD;
      of Dilapan-S® compared with Foley catheter for cervical ripening before induction of labor in&#xD;
      pregnant women greater than 37 weeks.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Actual">February 2018</completion_date>
  <primary_completion_date type="Actual">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Vaginal Delivery</measure>
    <time_frame>Through study completion, an average of 1-2 years</time_frame>
    <description>Proportion of patients that delivered vaginal. (%)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time of Vaginal Delivery</measure>
    <time_frame>2-4 days</time_frame>
    <description>Delivery time frame in mins from cervical dilator insertion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Reach Active Stage of Labor as ≥ 6cm Cervical Dilation</measure>
    <time_frame>1-2 days</time_frame>
    <description>time from hospital admission to reach active stage of labor defined as ≥ 6 cm (mins)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Bishop Scores</measure>
    <time_frame>12-24 hrs</time_frame>
    <description>Change in Bishop score from insertion to extraction of device. The total score is calculated by assessing the following five components on manual vaginal examination by a trained professional: Cervical dilation in centimeters. Cervical effacement as a percentage. Cervical consistency by provider assessment/judgement.&#xD;
The highest possible score is 13 and the lowest possible score is 0. Bishop scores of less than 6 usually require that a cervical ripening method (pharmacologic or physical, such as a foley bulb) be used before other method</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative Deliveries</measure>
    <time_frame>1-4 days</time_frame>
    <description>Proportion of patients that delivered vaginal by forceps assistance or vacuum (%) assistance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cesarean Deliveries</measure>
    <time_frame>1-4 days</time_frame>
    <description>Proportion of patients that delivered by cesarean (%).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Analgesia Requirement</measure>
    <time_frame>1-2 days</time_frame>
    <description>Rate of women who require any analgesia used during insertion of the device</description>
  </other_outcome>
  <other_outcome>
    <measure>Spontaneous Labor</measure>
    <time_frame>1-4 days</time_frame>
    <description>Rate of women underwent spontaneous labor (%)</description>
  </other_outcome>
  <other_outcome>
    <measure>Pharmacological Agents for Labor Induction (Prostaglandins, Oxytocin)(%)</measure>
    <time_frame>1-2 days</time_frame>
    <description>Rate of women that required pharmacological cervical ripening agents (%) requirement (%)</description>
  </other_outcome>
  <other_outcome>
    <measure>Artificial Rupture of Membranes (AROM)</measure>
    <time_frame>1-2 days</time_frame>
    <description>Rate of women that had artificial rupture of membranes (AROM) (%)</description>
  </other_outcome>
  <other_outcome>
    <measure>Regional Anesthesia</measure>
    <time_frame>1-2 days</time_frame>
    <description>Rate of epidural/spinal analgesia (%)</description>
  </other_outcome>
  <other_outcome>
    <measure>Device Insertion Time</measure>
    <time_frame>1-2 days</time_frame>
    <description>Total duration of Dilapan-S® /Foley catheter insertion (mins)</description>
  </other_outcome>
  <other_outcome>
    <measure>Device Placement to Delivery Interval</measure>
    <time_frame>1-4 days</time_frame>
    <description>Interval from device placement to delivery (mins)</description>
  </other_outcome>
  <other_outcome>
    <measure>Time After Mechanical Dilator</measure>
    <time_frame>1-2 days</time_frame>
    <description>Induction (Oxytocin/Prostaglandin initiation) to delivery interval (mins)</description>
  </other_outcome>
  <other_outcome>
    <measure>Comparison of Labor Curves Between Both Interventions</measure>
    <time_frame>1-2 days</time_frame>
    <description>Labor curves using Kaplan Meier method comparing Dilapan-S to Foley balloon</description>
  </other_outcome>
  <other_outcome>
    <measure>Device Complications</measure>
    <time_frame>1-2 days</time_frame>
    <description>Rates of complications resulting from device insertion (%):&#xD;
Vaginal bleeding Vaso-vagal reaction from manipulation of the cervix Cervical laceration Retraction into the uterine cavity Rupture of membranes (Date/Time) Entrapment of the device Fragmentation of the device in the genital tract Rates of complications associated with cervical ripening(%) Uterine tachysystole/hypertonus Non reassuring fetal status Systemic adverse events (nausea, vomiting, diarrhea, fever, hypotension, tachycardia)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">419</enrollment>
  <condition>Pre-induction Dilation of Cervix</condition>
  <arm_group>
    <arm_group_label>Foley Bulb Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will have a Foley catheter inserted into the internal cervical os.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dilapan Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will have Dilapan sticks inserted into the internal cervical os.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dilapan</intervention_name>
    <description>Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, synthetic osmotic dilators (Dilapan-S) are inserted into the cervical canal with special attention to cross through the internal os.</description>
    <arm_group_label>Dilapan Group</arm_group_label>
    <other_name>Osmotic cervical dilator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Foley Catheter</intervention_name>
    <description>Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, a Foley catheter is inserted into the cervix and the balloon is filled with 60 ml of sterile 0.9% NaCl.</description>
    <arm_group_label>Foley Bulb Group</arm_group_label>
    <other_name>Foley Bulb</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant woman scheduled for induction of labor.&#xD;
&#xD;
          -  Age between 18 and 45 years.&#xD;
&#xD;
          -  Understanding and capable to sign informed consent.&#xD;
&#xD;
          -  Singleton pregnancy.&#xD;
&#xD;
          -  Gestational age ≥ 37 0/7 weeks.&#xD;
&#xD;
          -  Live fetus in cephalic presentation.&#xD;
&#xD;
          -  Intact membranes.&#xD;
&#xD;
          -  Pelvic exam (sterile vaginal exam) of less than or equal to 3cm and at most 60%&#xD;
             effaced.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Iodine allergy.&#xD;
&#xD;
          -  Active labor or oxytocin has been administered.&#xD;
&#xD;
          -  Chorioamnionitis.&#xD;
&#xD;
          -  Prior uterine or cervical surgery.&#xD;
&#xD;
          -  Non reassuring fetal status requiring immediate delivery.&#xD;
&#xD;
          -  Non-cephalic fetal presentation.&#xD;
&#xD;
          -  Active vaginal bleeding from cervical os.&#xD;
&#xD;
          -  Placenta previa.&#xD;
&#xD;
          -  EFW &gt; 5000 gm(non diabetic) or &gt; 4500gm (diabetic).&#xD;
&#xD;
          -  Other contraindication to vaginal delivery.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Saad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UTMB Galveston</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>August 31, 2016</study_first_submitted>
  <study_first_submitted_qc>September 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2016</study_first_posted>
  <results_first_submitted>February 26, 2019</results_first_submitted>
  <results_first_submitted_qc>October 26, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 18, 2020</results_first_posted>
  <last_update_submitted>October 26, 2020</last_update_submitted>
  <last_update_submitted_qc>October 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Labor</keyword>
  <keyword>Foley</keyword>
  <keyword>Dilapan</keyword>
  <keyword>Cervical Dilators</keyword>
  <keyword>Induction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 24, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/89/NCT02899689/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>From November 2016 to February 2018 at UTMB Galveston</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Foley Bulb Group</title>
          <description>Patients will have a Foley catheter inserted into the internal cervical os.&#xD;
Foley Catheter: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, a Foley catheter is inserted into the cervix and the balloon is filled with 60 ml of sterile 0.9% NaCl.</description>
        </group>
        <group group_id="P2">
          <title>Dilapan Group</title>
          <description>Patients will have Dilapan sticks inserted into the internal cervical os.&#xD;
Dilapan: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, synthetic osmotic dilators (Dilapan-S) are inserted into the cervical canal with special attention to cross through the internal os.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="209"/>
                <participants group_id="P2" count="210"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="209"/>
                <participants group_id="P2" count="208"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>These demographics includes all that were randomized. 2 participants withdrew consent in the dilapan group.</population>
      <group_list>
        <group group_id="B1">
          <title>Foley Bulb Group</title>
          <description>Patients will have a Foley catheter inserted into the internal cervical os.&#xD;
Foley Catheter: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, a Foley catheter is inserted into the cervix and the balloon is filled with 60 ml of sterile 0.9% NaCl.</description>
        </group>
        <group group_id="B2">
          <title>Dilapan Group</title>
          <description>Patients will have Dilapan sticks inserted into the internal cervical os.&#xD;
Dilapan: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, synthetic osmotic dilators (Dilapan-S) are inserted into the cervical canal with special attention to cross through the internal os.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="209"/>
            <count group_id="B2" value="210"/>
            <count group_id="B3" value="419"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25" lower_limit="18" upper_limit="44"/>
                    <measurement group_id="B2" value="25" lower_limit="18" upper_limit="44"/>
                    <measurement group_id="B3" value="25" lower_limit="18" upper_limit="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="209"/>
                    <measurement group_id="B2" value="210"/>
                    <measurement group_id="B3" value="419"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="147"/>
                    <measurement group_id="B2" value="153"/>
                    <measurement group_id="B3" value="300"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="119"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="209"/>
                    <measurement group_id="B2" value="210"/>
                    <measurement group_id="B3" value="419"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational age</title>
          <units>weeks</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39.0" lower_limit="39" upper_limit="41"/>
                    <measurement group_id="B2" value="39" lower_limit="37" upper_limit="41"/>
                    <measurement group_id="B3" value="39" lower_limit="39" upper_limit="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Nulliparous</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="98"/>
                    <measurement group_id="B2" value="88"/>
                    <measurement group_id="B3" value="186"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Bishop score at randomization</title>
          <description>The total score is calculated by assessing the following five components on manual vaginal examination by a trained professional: Cervical dilation in centimeters. Cervical effacement as a percentage. Cervical consistency by provider assessment/judgement.&#xD;
The highest possible score is 13 and the lowest possible score is 0. Bishop scores of less than 6 usually require that a cervical ripening method (pharmacologic or physical, such as a foley bulb) be used before other method</description>
          <units>scores on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3" lower_limit="0" upper_limit="7"/>
                    <measurement group_id="B2" value="3" lower_limit="0" upper_limit="8"/>
                    <measurement group_id="B3" value="3" lower_limit="0" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Rate of Vaginal Delivery</title>
        <description>Proportion of patients that delivered vaginal. (%)</description>
        <time_frame>Through study completion, an average of 1-2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Group</title>
            <description>Patients will have a Foley catheter inserted into the internal cervical os.&#xD;
Foley Catheter: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, a Foley catheter is inserted into the cervix and the balloon is filled with 60 ml of sterile 0.9% NaCl.</description>
          </group>
          <group group_id="O2">
            <title>Dilapan Group</title>
            <description>Patients will have Dilapan sticks inserted into the internal cervical os.&#xD;
Dilapan: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, synthetic osmotic dilators (Dilapan-S) are inserted into the cervical canal with special attention to cross through the internal os.</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Vaginal Delivery</title>
          <description>Proportion of patients that delivered vaginal. (%)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="208"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="169"/>
                    <measurement group_id="O2" value="159"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time of Vaginal Delivery</title>
        <description>Delivery time frame in mins from cervical dilator insertion</description>
        <time_frame>2-4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Group</title>
            <description>Patients will have a Foley catheter inserted into the internal cervical os.&#xD;
Foley Catheter: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, a Foley catheter is inserted into the cervix and the balloon is filled with 60 ml of sterile 0.9% NaCl.</description>
          </group>
          <group group_id="O2">
            <title>Dilapan Group</title>
            <description>Patients will have Dilapan sticks inserted into the internal cervical os.&#xD;
Dilapan: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, synthetic osmotic dilators (Dilapan-S) are inserted into the cervical canal with special attention to cross through the internal os.</description>
          </group>
        </group_list>
        <measure>
          <title>Time of Vaginal Delivery</title>
          <description>Delivery time frame in mins from cervical dilator insertion</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="208"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1291" lower_limit="1203" upper_limit="1408"/>
                    <measurement group_id="O2" value="1441" lower_limit="1343" upper_limit="1521"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Reach Active Stage of Labor as ≥ 6cm Cervical Dilation</title>
        <description>time from hospital admission to reach active stage of labor defined as ≥ 6 cm (mins)</description>
        <time_frame>1-2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Group</title>
            <description>Patients will have a Foley catheter inserted into the internal cervical os.&#xD;
Foley Catheter: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, a Foley catheter is inserted into the cervix and the balloon is filled with 60 ml of sterile 0.9% NaCl.</description>
          </group>
          <group group_id="O2">
            <title>Dilapan Group</title>
            <description>Patients will have Dilapan sticks inserted into the internal cervical os.&#xD;
Dilapan: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, synthetic osmotic dilators (Dilapan-S) are inserted into the cervical canal with special attention to cross through the internal os.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Reach Active Stage of Labor as ≥ 6cm Cervical Dilation</title>
          <description>time from hospital admission to reach active stage of labor defined as ≥ 6 cm (mins)</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="208"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1011" lower_limit="913" upper_limit="1074"/>
                    <measurement group_id="O2" value="1152" lower_limit="1092" upper_limit="1205"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Bishop Scores</title>
        <description>Change in Bishop score from insertion to extraction of device. The total score is calculated by assessing the following five components on manual vaginal examination by a trained professional: Cervical dilation in centimeters. Cervical effacement as a percentage. Cervical consistency by provider assessment/judgement.&#xD;
The highest possible score is 13 and the lowest possible score is 0. Bishop scores of less than 6 usually require that a cervical ripening method (pharmacologic or physical, such as a foley bulb) be used before other method</description>
        <time_frame>12-24 hrs</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Group</title>
            <description>Patients will have a Foley catheter inserted into the internal cervical os.&#xD;
Foley Catheter: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, a Foley catheter is inserted into the cervix and the balloon is filled with 60 ml of sterile 0.9% NaCl.</description>
          </group>
          <group group_id="O2">
            <title>Dilapan Group</title>
            <description>Patients will have Dilapan sticks inserted into the internal cervical os.&#xD;
Dilapan: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, synthetic osmotic dilators (Dilapan-S) are inserted into the cervical canal with special attention to cross through the internal os.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Bishop Scores</title>
          <description>Change in Bishop score from insertion to extraction of device. The total score is calculated by assessing the following five components on manual vaginal examination by a trained professional: Cervical dilation in centimeters. Cervical effacement as a percentage. Cervical consistency by provider assessment/judgement.&#xD;
The highest possible score is 13 and the lowest possible score is 0. Bishop scores of less than 6 usually require that a cervical ripening method (pharmacologic or physical, such as a foley bulb) be used before other method</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="208"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="-3" upper_limit="9"/>
                    <measurement group_id="O2" value="2" lower_limit="-2" upper_limit="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Operative Deliveries</title>
        <description>Proportion of patients that delivered vaginal by forceps assistance or vacuum (%) assistance.</description>
        <time_frame>1-4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Group</title>
            <description>Patients will have a Foley catheter inserted into the internal cervical os.&#xD;
Foley Catheter: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, a Foley catheter is inserted into the cervix and the balloon is filled with 60 ml of sterile 0.9% NaCl.</description>
          </group>
          <group group_id="O2">
            <title>Dilapan Group</title>
            <description>Patients will have Dilapan sticks inserted into the internal cervical os.&#xD;
Dilapan: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, synthetic osmotic dilators (Dilapan-S) are inserted into the cervical canal with special attention to cross through the internal os.</description>
          </group>
        </group_list>
        <measure>
          <title>Operative Deliveries</title>
          <description>Proportion of patients that delivered vaginal by forceps assistance or vacuum (%) assistance.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="208"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cesarean Deliveries</title>
        <description>Proportion of patients that delivered by cesarean (%).</description>
        <time_frame>1-4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Group</title>
            <description>Patients will have a Foley catheter inserted into the internal cervical os.&#xD;
Foley Catheter: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, a Foley catheter is inserted into the cervix and the balloon is filled with 60 ml of sterile 0.9% NaCl.</description>
          </group>
          <group group_id="O2">
            <title>Dilapan Group</title>
            <description>Patients will have Dilapan sticks inserted into the internal cervical os.&#xD;
Dilapan: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, synthetic osmotic dilators (Dilapan-S) are inserted into the cervical canal with special attention to cross through the internal os.</description>
          </group>
        </group_list>
        <measure>
          <title>Cesarean Deliveries</title>
          <description>Proportion of patients that delivered by cesarean (%).</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="208"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Analgesia Requirement</title>
        <description>Rate of women who require any analgesia used during insertion of the device</description>
        <time_frame>1-2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Group</title>
            <description>Patients will have a Foley catheter inserted into the internal cervical os.&#xD;
Foley Catheter: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, a Foley catheter is inserted into the cervix and the balloon is filled with 60 ml of sterile 0.9% NaCl.</description>
          </group>
          <group group_id="O2">
            <title>Dilapan Group</title>
            <description>Patients will have Dilapan sticks inserted into the internal cervical os.&#xD;
Dilapan: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, synthetic osmotic dilators (Dilapan-S) are inserted into the cervical canal with special attention to cross through the internal os.</description>
          </group>
        </group_list>
        <measure>
          <title>Analgesia Requirement</title>
          <description>Rate of women who require any analgesia used during insertion of the device</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="208"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Spontaneous Labor</title>
        <description>Rate of women underwent spontaneous labor (%)</description>
        <time_frame>1-4 days</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Pharmacological Agents for Labor Induction (Prostaglandins, Oxytocin)(%)</title>
        <description>Rate of women that required pharmacological cervical ripening agents (%) requirement (%)</description>
        <time_frame>1-2 days</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Artificial Rupture of Membranes (AROM)</title>
        <description>Rate of women that had artificial rupture of membranes (AROM) (%)</description>
        <time_frame>1-2 days</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Regional Anesthesia</title>
        <description>Rate of epidural/spinal analgesia (%)</description>
        <time_frame>1-2 days</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Device Insertion Time</title>
        <description>Total duration of Dilapan-S® /Foley catheter insertion (mins)</description>
        <time_frame>1-2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Group</title>
            <description>Patients will have a Foley catheter inserted into the internal cervical os.&#xD;
Foley Catheter: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, a Foley catheter is inserted into the cervix and the balloon is filled with 60 ml of sterile 0.9% NaCl.</description>
          </group>
          <group group_id="O2">
            <title>Dilapan Group</title>
            <description>Patients will have Dilapan sticks inserted into the internal cervical os.&#xD;
Dilapan: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, synthetic osmotic dilators (Dilapan-S) are inserted into the cervical canal with special attention to cross through the internal os.</description>
          </group>
        </group_list>
        <measure>
          <title>Device Insertion Time</title>
          <description>Total duration of Dilapan-S® /Foley catheter insertion (mins)</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="208"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="666" spread="319"/>
                    <measurement group_id="O2" value="774.1" spread="295"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Device Placement to Delivery Interval</title>
        <description>Interval from device placement to delivery (mins)</description>
        <time_frame>1-4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Group</title>
            <description>Patients will have a Foley catheter inserted into the internal cervical os.&#xD;
Foley Catheter: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, a Foley catheter is inserted into the cervix and the balloon is filled with 60 ml of sterile 0.9% NaCl.</description>
          </group>
          <group group_id="O2">
            <title>Dilapan Group</title>
            <description>Patients will have Dilapan sticks inserted into the internal cervical os.&#xD;
Dilapan: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, synthetic osmotic dilators (Dilapan-S) are inserted into the cervical canal with special attention to cross through the internal os.</description>
          </group>
        </group_list>
        <measure>
          <title>Device Placement to Delivery Interval</title>
          <description>Interval from device placement to delivery (mins)</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="208"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1291" lower_limit="1203" upper_limit="1408"/>
                    <measurement group_id="O2" value="1441" lower_limit="1343" upper_limit="1521"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Time After Mechanical Dilator</title>
        <description>Induction (Oxytocin/Prostaglandin initiation) to delivery interval (mins)</description>
        <time_frame>1-2 days</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Comparison of Labor Curves Between Both Interventions</title>
        <description>Labor curves using Kaplan Meier method comparing Dilapan-S to Foley balloon</description>
        <time_frame>1-2 days</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Device Complications</title>
        <description>Rates of complications resulting from device insertion (%):&#xD;
Vaginal bleeding Vaso-vagal reaction from manipulation of the cervix Cervical laceration Retraction into the uterine cavity Rupture of membranes (Date/Time) Entrapment of the device Fragmentation of the device in the genital tract Rates of complications associated with cervical ripening(%) Uterine tachysystole/hypertonus Non reassuring fetal status Systemic adverse events (nausea, vomiting, diarrhea, fever, hypotension, tachycardia)</description>
        <time_frame>1-2 days</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Duration of the trial: up to 2 weeks after discharge from hospital</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Foley Bulb Group</title>
          <description>Patients will have a Foley catheter inserted into the internal cervical os.&#xD;
Foley Catheter: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, a Foley catheter is inserted into the cervix and the balloon is filled with 60 ml of sterile 0.9% NaCl.</description>
        </group>
        <group group_id="E2">
          <title>Dilapan Group</title>
          <description>Patients will have Dilapan sticks inserted into the internal cervical os.&#xD;
Dilapan: Using a sterile speculum, the cervix is visualized and cleaned with iodine. Under direct visualization, synthetic osmotic dilators (Dilapan-S) are inserted into the cervical canal with special attention to cross through the internal os.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="208"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="209"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="208"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Motor vehicle collision</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>1 motor vehicle accident - occurred postpartum within 2 weeks of delivery. Resulted in prolonged hospitalization</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="208"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Serious Adverse event</sub_title>
                <description>Skin breakdown from mobility due to epidural. Unrelated to the study since device was already removed and epidural placed after the intervention (Foley balloon ) was removed. Occurred in the postpartum period</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="209"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="208"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="209"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="208"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Antonio F Saad</name_or_title>
      <organization>UTMB</organization>
      <phone>4097720982</phone>
      <email>afsaad@utmb.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

